Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Urinary Bladder Neoplasms"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 70293
Tytuł:
MRI evaluation of vesical imaging reporting and data system for bladder cancer after neoadjuvant chemotherapy.
Autorzy:
Zhang X; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang Y; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang Y; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhang J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhang J; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhang L; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang S; GE Healthcare, MR Research China, Beijing, 100176, China.
Shou J; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Chen Y; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Zhao X; Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Pokaż więcej
Źródło:
Cancer imaging : the official publication of the International Cancer Imaging Society [Cancer Imaging] 2024 Apr 08; Vol. 24 (1), pp. 49. Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder*/diagnostic imaging
Urinary Bladder*/pathology
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/pathology
Male ; Humans ; Adult ; Middle Aged ; Aged ; Neoadjuvant Therapy ; Retrospective Studies ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Szczegóły
Tytuł:
Physical Activity and Bladder Cancer Risk: Findings of the Japan Collaborative Cohort Study.
Autorzy:
An H; Division of Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Japan.; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.; Institute of Reproductive and Child Health/Ministry of Health Key Laboratory of Reproductive Health, Peking University Health Science Center, Beijing, China.
Liu K; Division of Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Shirai K; Division of Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Kawasaki R; Division of Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine, Suita, Japan.
Tamakoshi A; Department of Public Health, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
Iso H; Institute for Global Health Policy Research (iGHP), Bureau of International Health Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Pokaż więcej
Źródło:
Cancer research and treatment [Cancer Res Treat] 2024 Apr; Vol. 56 (2), pp. 616-623. Date of Electronic Publication: 2023 Oct 06.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise*
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/etiology
Adult ; Male ; Humans ; Female ; Cohort Studies ; Japan/epidemiology ; Prospective Studies ; Risk Factors ; Incidence
Czasopismo naukowe
Szczegóły
Tytuł:
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive bladder cancer.
Autorzy:
von Deimling M; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Furrer M; Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland.; Department of Urology, Solothurner Spitäler AG, Olten, Solothurn, Switzerland.
Mertens LS; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Mari A; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
van Ginkel N; Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bacchiani M; Unit of Oncologic Minimally-Invasive Urology and Andrology, Department of Experimental and Clinical Medicine, Careggi Hospital, University of Florence, Florence, Italy.
Maas M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Urology, Eberhard Karls University Tübingen, Tübingen, Germany.
Pichler R; Department of Urology, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, Innsbruck, Austria.
Li R; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Moschini M; Department of Urology, Urological Research Institute, Milan, Italy.
Bianchi A; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Vetterlein MW; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lonati C; Department of Urology, Spedali Civili of Brescia, Brescia, Italy.
Crocetto F; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples 'Federico II', Naples, Italy.
Taylor J; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
Tully KH; Department of Urology and Neurourology, Marien Hospital Herne, Ruhr-University Bochum, Herne, Germany.
Afferi L; Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland.
Soria F; Division of Urology, Department of Surgical Sciences, San Giovanni Battista Hospital, University of Studies of Torino, Turin, Italy.
Del Giudice F; Department of Maternal Infant and Urologic Sciences, 'Sapienza' University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
Longoni M; Department of Urology, Urological Research Institute, Milan, Italy.
Laukhtina E; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Antonelli A; Department of Urology, University of Verona, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lotan Y; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.
Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.
Kiss B; Department of Urology, University Hospital of Bern, University of Bern, Bern, Switzerland.
Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, Urosud, La Croix Du Sud Hospital, Quint-Fonsegrives, France.
Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Urology, University of Texas Southwestern, Dallas, TX, USA.; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria.; Department of Urology, Weill Cornell Medical College, New York, NY, USA.; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic.
Pokaż więcej
Corporate Authors:
CLIPOLY Study Group Collaborators
Źródło:
BJU international [BJU Int] 2024 Mar; Vol. 133 (3), pp. 341-350. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Neoplasm Recurrence, Local*/pathology
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Retrospective Studies ; Lymph Node Excision ; Lymph Nodes/surgery ; Lymph Nodes/pathology ; Cystectomy
Czasopismo naukowe
Szczegóły
Tytuł:
Development and validation of a nomogram for predicting suicide risk and prognostic factors in bladder cancer patients following diagnosis: A population-based retrospective study.
Autorzy:
Liu L; Department of Urology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China; Prostate & Andrology Key Laboratory of Baoding, Baoding 071000, Hebei, China. Electronic address: .
Xiao Y; Psychosomatic Medical Center, The Fourth People's Hospital of Chengdu, Chengdu 610036, Sichuan, China; Psychosomatic Medical Center, The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, University of Electronic Science and Technology of China, Chengdu 610036, Sichuan, China.
Wei D; Department of Surgery and Urology, Hebei General Hospital, Shijiazhuang 050051, China.
Wang Q; Department of Urology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China; Prostate & Andrology Key Laboratory of Baoding, Baoding 071000, Hebei, China.
Zhang JK; Department of Pathology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China.
Yuan L; Department of Urology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China.
Bai GQ; Department of Urology, Baoding No.1 Central Hospital, Baoding 071000, Hebei, China.
Pokaż więcej
Źródło:
Journal of affective disorders [J Affect Disord] 2024 Feb 15; Vol. 347, pp. 124-133. Date of Electronic Publication: 2023 Nov 22.
Typ publikacji:
Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nomograms*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/epidemiology
Humans ; Prognosis ; Retrospective Studies ; Risk Factors ; Neoplasm Staging
Czasopismo naukowe
Szczegóły
Tytuł:
Amide Proton Transfer-Weighted MRI and Diffusion-Weighted Imaging in Bladder Cancer: A Complementary Tool to the VI-RADS.
Autorzy:
Kong L; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Wen Z; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Cai Q; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Lin Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Chen Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Cao W; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Li M; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Qian L; MR Research, GE Healthcare, Beijing, China (L.Q.).
Chen J; Department of Urology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (J.C.).
Guo Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.).
Wang H; Department of Radiology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, PR China (L.K., Z.W., Q.C., Y.L., Y.C., W.C., M.L., Y.G., H.W.). Electronic address: .
Pokaż więcej
Źródło:
Academic radiology [Acad Radiol] 2024 Feb; Vol. 31 (2), pp. 564-571. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:
Journal Article
MeSH Terms:
Non-Muscle Invasive Bladder Neoplasms*
Urinary Bladder Neoplasms*/diagnostic imaging
Urinary Bladder Neoplasms*/pathology
Male ; Humans ; Middle Aged ; Aged ; Protons ; Prospective Studies ; Magnetic Resonance Imaging/methods ; Diffusion Magnetic Resonance Imaging/methods ; Amides ; Retrospective Studies
Czasopismo naukowe
Szczegóły
Tytuł:
CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell proliferation, migration and invasion.
Autorzy:
Wang C; Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, Liaoning Province, China.
Yang X; Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou 121000, Liaoning Province, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Apr 20; Vol. 131, pp. 111613. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
RNA, Circular*/metabolism
Animals ; Humans ; Mice ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Gene Expression Regulation, Neoplastic ; Kinesins/genetics ; Kinesins/metabolism
Czasopismo naukowe
Szczegóły
Tytuł:
Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses.
Autorzy:
Wang B; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Zhou B; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Chen J; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Sun X; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Yang W; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Department of Hematology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Yang T; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Yu H; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Chen P; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Chen K; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Huang X; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Fan X; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
He W; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Huang J; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Lin T; Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China .; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-sen (Zhongshan) University, Guangzhou, China.
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Apr 08; Vol. 12 (4). Date of Electronic Publication: 2024 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Interferon Lambda*
Urinary Bladder Neoplasms*/drug therapy
Animals ; Mice ; Humans ; CD8-Positive T-Lymphocytes ; Macrophages ; Immunity ; Phagocytosis ; Tumor Microenvironment
Czasopismo naukowe
Szczegóły
Tytuł:
Clinical performance and utility of a noninvasive urine-based methylation biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Autorzy:
Zhang C; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Xu X; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Y; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Lu Z; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Wang T; Jiangsu MicroDiag Biomedicine Co., Ltd., Suzhou, China.
Pan Z; Zhejiang Cancer Hospital, Hangzhou, 310022, Zhejiang , China. pan_.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China. pan_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7941. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Humans ; Urinary Bladder/pathology ; Vimentin/genetics ; Biomarkers, Tumor/metabolism ; DNA Methylation/genetics ; Nuclear Proteins/genetics ; Twist-Related Protein 1/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancer.
Autorzy:
Swinton M; Christie Hospital NHS Foundation Trust, Manchester, UK.; University of Manchester, Manchester, UK.
Devi A; Christie Hospital NHS Foundation Trust, Manchester, UK.
Song YP; Christie Hospital NHS Foundation Trust, Manchester, UK.
Hoskin P; Christie Hospital NHS Foundation Trust, Manchester, UK.; University of Manchester, Manchester, UK.
Choudhury A; Christie Hospital NHS Foundation Trust, Manchester, UK. .; University of Manchester, Manchester, UK. .
Pokaż więcej
Źródło:
World journal of urology [World J Urol] 2024 Apr 04; Vol. 42 (1), pp. 210. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Urinary Bladder*/surgery
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/surgery
Humans ; Cystectomy ; Immune Checkpoint Inhibitors ; Muscles
Czasopismo naukowe
Szczegóły
Tytuł:
Association of preoperative sarcopenia with the long-term prognosis of patients with bladder cancer undergoing radical cystectomy.
Autorzy:
Lee S; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Yoon Y; Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Suh J; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
You D; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hong B; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Hong JH; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Ahn H; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Jeong IG; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.
Lim B; Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Apr 03; Vol. 150 (4), pp. 173. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Journal Article
MeSH Terms:
Sarcopenia*/complications
Sarcopenia*/diagnostic imaging
Urinary Bladder Neoplasms*/surgery
Humans ; Cystectomy ; Retrospective Studies ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
Assessing the Causal Relationship between Waterpipe Smoking and Bladder Cancer.
Autorzy:
Rosser CJ; Department of Urology, Cedars-Sinai Medical Center, Los Angeles, California.
Pokaż więcej
Źródło:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Apr 03; Vol. 33 (4), pp. 461-462.
Typ publikacji:
Journal Article
MeSH Terms:
Water Pipe Smoking*/adverse effects
Water Pipe Smoking*/epidemiology
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/etiology
Humans ; Case-Control Studies ; Smokers ; Iran/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A Multicenter Case-Control Study in Iran.
Autorzy:
Hadji M; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.
Rashidian H; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.
Marzban M; Department of Public Health, School of Public Health, Bushehr University of Medical Science, Bushehr, Iran.; Clinical Research Development Center, The Persian Gulf Martyrs, Bushehr University of Medical Science, Bushehr, Iran.
Rezaianzadeh A; Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Ansari-Moghaddam A; Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Bakhshi M; Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
Nejatizadeh A; Tobacco and Health Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
Seyyedsalehi MS; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Naghibzadeh-Tahami A; Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Department of Biostatistics and Epidemiology, Kerman University of Medical Sciences, Kerman, Iran.
Haghdoost A; Department of Biostatistics and Epidemiology, Kerman University of Medical Sciences, Kerman, Iran.; Regional Knowledge HUB for HIV/AIDS Surveillance, Research Centre for Modelling in Health, Institute for Future Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
Mohebbi E; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Oncology, Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia.
Freedman ND; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
Malekzadeh R; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Etemadi A; Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.; Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Kamangar F; Department of Biology, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, Maryland.
Weiderpass E; International Agency for Research on Cancer, Lyon, France.
Pukkala E; Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.; Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland.
Boffetta P; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York.
Zendehdel K; Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Iran.; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Apr 03; Vol. 33 (4), pp. 509-515.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Water Pipe Smoking*/adverse effects
Water Pipe Smoking*/epidemiology
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/etiology
Humans ; Iran/epidemiology ; Case-Control Studies ; Opium ; Nicotiana
Czasopismo naukowe
Szczegóły
Tytuł:
Investigating the impact of regulatory B cells and regulatory B cell-related genes on bladder cancer progression and immunotherapeutic sensitivity.
Autorzy:
Zhou J; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Zhou R; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Zhu Y; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Deng S; Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1023-1063 Shatai South Road, Baiyun District, Guangzhou, Guangdong, 510080, China.
Muhuitijiang B; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Li C; Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1023-1063 Shatai South Road, Baiyun District, Guangzhou, Guangdong, 510080, China.
Shi X; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China.; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China.
Zhang L; Department of Transfusion Medicine, School of Laboratory Medicine and Biotechnology, Southern Medical University, No. 1023-1063 Shatai South Road, Baiyun District, Guangzhou, Guangdong, 510080, China. .
Tan W; Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, 510080, China. .; The First Clinical Medical College, Southern Medical University, Guangzhou, Guangdong, 510080, China. .
Pokaż więcej
Źródło:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Apr 02; Vol. 43 (1), pp. 101. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
B-Lymphocytes, Regulatory*
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Humans ; CD8-Positive T-Lymphocytes ; Flow Cytometry ; Immunotherapy ; Prognosis
Czasopismo naukowe
Szczegóły
Tytuł:
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma.
Autorzy:
Nishiyama H; Department of Urology, University of Tsukuba, Tsukuba, Japan.
Yonese J; Department of Urology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
Kawahara T; Department of Urology, University of Tsukuba, Tsukuba, Japan.
Matsumoto R; Department of Renal and Genitourinary Surgery, Hokkaido University, Sapporo, Japan.
Miyake H; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Matsubara N; Division of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.
Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Eto M; Department of Urology, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Azuma H; Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
Obara W; Department of Urology, Iwate Medical University, Yahaba, Japan.
Terai A; Department of Urology, Kurashiki Central Hospital, Kurashiki, Japan.
Fukasawa S; Prostate Center and Division of Urology, Chiba Cancer Center, Chiba, Japan.
Suekane S; Department of Urology, Kurume University School of Medicine, Kurume, Japan.
Pokaż więcej
Źródło:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Apr 02; Vol. 23 (4), pp. 532-540.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/drug therapy
Antineoplastic Agents, Immunological*/adverse effects
Urinary Bladder Neoplasms*/drug therapy
Urinary Bladder Neoplasms*/etiology
Antibodies, Monoclonal, Humanized*
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; B7-H1 Antigen/metabolism ; Antineoplastic Combined Chemotherapy Protocols/adverse effects
Czasopismo naukowe
Szczegóły
Tytuł:
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.
Autorzy:
Pilala KM; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Kotronopoulos G; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Levis P; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Giagkos GC; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Stravodimos K; First Department of Urology, 'Laiko' General Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Vassilacopoulou D; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Scorilas A; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
Avgeris M; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.; Laboratory of Clinical Biochemistry-Molecular Diagnostics, Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, 'P. & A. Kyriakou' Children's Hospital, Athens, Greece.
Pokaż więcej
Źródło:
JCO precision oncology [JCO Precis Oncol] 2024 Apr; Vol. 8, pp. e2300414.
Typ publikacji:
Journal Article
MeSH Terms:
Cell-Free Nucleic Acids*/genetics
Cell-Free Nucleic Acids*/therapeutic use
MicroRNAs*/genetics
MicroRNAs*/therapeutic use
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Urinary Bladder Neoplasms*/therapy
Humans ; Liquid Biopsy ; Methylation ; Muscles/pathology ; Neoplasm Recurrence, Local/pathology ; Treatment Outcome ; DNA Methylation/genetics
Czasopismo naukowe
Szczegóły
Tytuł:
Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma.
Autorzy:
Tekin B; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Erickson LA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Gupta S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
Pokaż więcej
Źródło:
Mayo Clinic proceedings [Mayo Clin Proc] 2024 Apr; Vol. 99 (4), pp. 680-682.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/pathology
Endometrial Neoplasms*/diagnosis
Endometrial Neoplasms*/pathology
Carcinoma, Transitional Cell*/pathology
Female ; Humans ; Urinary Bladder/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy.
Autorzy:
Luo HL; Department of Urology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Kaohsiung, Taiwan.
Pokaż więcej
Źródło:
International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 Apr; Vol. 31 (4), pp. 421. Date of Electronic Publication: 2024 Apr 03.
Typ publikacji:
Letter
MeSH Terms:
Carcinoma, Transitional Cell*/surgery
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Kidney Neoplasms*/surgery
Kidney Neoplasms*/pathology
Ureteral Neoplasms*/surgery
Ureteral Neoplasms*/pathology
Humans ; Nephroureterectomy ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Recurrence, Local/prevention & control ; Neoplasm Recurrence, Local/pathology ; Retrospective Studies
Opinia redakcyjna
Szczegóły
Tytuł:
Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its Association with Tumour Grade.
Autorzy:
Nahar R; Dr Rejwana Nahar, Assistant Professor, Department of Pathology, Mugda Medical College, Dhaka, Bangladesh; E-mail: .
Jinnah MSA
Karim SS
Alam MM
Khatun J
Kabir E
Aktar M
Pokaż więcej
Źródło:
Mymensingh medical journal : MMJ [Mymensingh Med J] 2024 Apr; Vol. 33 (2), pp. 461-465.
Typ publikacji:
Observational Study; Journal Article
MeSH Terms:
Carcinoma, Transitional Cell*/metabolism
Carcinoma, Transitional Cell*/pathology
Urinary Bladder Neoplasms*/metabolism
Urinary Bladder Neoplasms*/pathology
Female ; Humans ; Male ; Bangladesh/epidemiology ; Cross-Sectional Studies ; Cyclin D1/metabolism ; Urinary Bladder/metabolism ; Urinary Bladder/pathology
Czasopismo naukowe
Szczegóły
Tytuł:
Bladder cancer: An Update.
Autorzy:
Pullen RL Jr; Richard Pullen is a professor at the Texas Tech University Health Sciences Center and is a member of the Nursing2024 editorial board.
Pokaż więcej
Źródło:
Nursing [Nursing] 2024 Apr 01; Vol. 54 (4), pp. 27-39. Date of Electronic Publication: 2024 Mar 22.
Typ publikacji:
Journal Article
MeSH Terms:
Urinary Bladder Neoplasms*/therapy
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/genetics
Carcinoma, Transitional Cell*/pathology
Humans ; Risk Factors
Czasopismo naukowe
Szczegóły
Tytuł:
Estimates of the lead time in screening for bladder cancer.
Autorzy:
Benbassat J; Department of Medicine (retired), Hadassah University Hospital Jerusalem, Israel. Electronic address: .
Pokaż więcej
Źródło:
Urologic oncology [Urol Oncol] 2024 Apr; Vol. 42 (4), pp. 110-114. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Early Detection of Cancer*
Urinary Bladder Neoplasms*/diagnosis
Urinary Bladder Neoplasms*/epidemiology
Urinary Bladder Neoplasms*/complications
Humans ; Retrospective Studies ; Prospective Studies ; Hematuria/etiology
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-20 z 70293

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies